Santen Pharmaceutical. (SNPHF) Q1 2026 Earnings

5FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
0.12
0.14
0.16
0.19

Details

Expected EPS
0.186918364998
Actual EPS
0.1556964
Surprise EPS
-0.03
Surprise Percent
+16.7%

Description

Santen Pharmaceutical. (SNPHF) has reported earnings of 0.1556964 per share for Q1 2026.

0 Comments

Share your thoughts